GeneOne Life Science진원생명과학
011000 · KOSPI · ₩011000 · 진원생명과학
₩2,670 ₩0 (0.00%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- Other Market Notice (Announcement of Results of Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 결과 안내)Oct 29, 2026Open on DART
High impactPredicted impact: High
Listing qualification substantive review result for a ₩48.5B company is a serious delisting-risk event.
- [Amended Filing] Major Matters Report (Decision on Sale of Own Convertible Bonds)[기재정정]주요사항보고서(자기전환사채매도결정)Oct 29, 2026Open on DART
Predicted impact: Low
- Other management matters기타경영사항(종속회사의주요경영사항)Oct 23, 2026Open on DART
Predicted impact: Low
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Oct 23, 2026Open on DART
Predicted impact: Low
- Lawsuit filed or ruled소송등의판결ㆍ결정(일정금액이상의청구)Oct 21, 2026Open on DART
Predicted impact: Medium
Lawsuit filing follows the recent ₩106.5B court ruling in the Innovio case, large against ₩12B revenue.
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Oct 15, 2026Open on DART
Predicted impact: Low· Actual: −8.9% vs sector (5 trading days)
- [Amended] Notice of Shareholder Register Closure Period or Record Date Setting[기재정정]주주명부폐쇄기간또는기준일설정Oct 14, 2026Open on DART
Predicted impact: Low· Actual: −8.9% vs sector (5 trading days)
- Amended: Shareholders' meeting called[기재정정]주주총회소집결의Oct 14, 2026Open on DART
Predicted impact: Low· Actual: −8.9% vs sector (5 trading days)
- Amended: Other management matters[기재정정]기타경영사항(종속회사의주요경영사항)Oct 12, 2026Open on DART
Predicted impact: Low· Actual: −6.9% vs sector (5 trading days)
- Amended: Other management matters[기재정정]기타경영사항(종속회사의주요경영사항)Oct 8, 2026Open on DART
- Material Matters Report (Decision on Acquisition of Own Convertible Bonds Before Maturity)주요사항보고서(자기전환사채만기전취득결정)Oct 7, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Sep 30, 2026Open on DART
- Other Market Notice (Notice of Extension of Listing Committee Review Deadline)기타시장안내 (기업심사위원회 개최기한 연장안내)Sep 28, 2026Open on DART
- Other management matters기타경영사항(종속회사의주요경영사항)Sep 23, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Sep 18, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Sep 18, 2026Open on DART
- Designation as Company for Unfaithful Disclosure불성실공시법인지정Sep 4, 2026Open on DART
- [Amendment] Decision on Debt Guarantee to Third Party[기재정정]타인에대한채무보증결정Sep 2, 2026Open on DART
- Other Market Notice (Submission of Improvement Plan)기타시장안내 (개선계획서 제출)Aug 31, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Aug 24, 2026Open on DART
- Occurrence of Adverse Opinion, Disclaimer of Opinion, or Complete Capital Impairment in Semi-Annual Review Report반기검토의견부적정,의견거절또는완전자본잠식사실발생Aug 14, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Aug 10, 2026Open on DART
- Market Notice (Decision on Items for Deliberation by the Corporate Review Committee)기타시장안내 (기업심사위원회 심의대상 결정)Aug 7, 2026Open on DART
- Other management matters기타경영사항(자율공시)Aug 6, 2026Open on DART
- Change of Representative Director (Representative Executive Officer) (Informational Disclosure)대표이사(대표집행임원)변경(안내공시)Aug 6, 2026Open on DART
- Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Aug 5, 2026Open on DART
- Notice of Planned Designation as Unfaithful Disclosure Company불성실공시법인지정예고Aug 4, 2026Open on DART
- Lawsuit filed or ruled소송등의제기ㆍ신청(일정금액이상의청구)Aug 4, 2026Open on DART
- Exchange inquiry about a news report or price move조회공시요구(풍문또는보도)Aug 3, 2026Open on DART
- [Amended Filing] Major Matters Report (Decision on Sale of Own Convertible Bonds)[기재정정]주요사항보고서(자기전환사채매도결정)Jul 30, 2026Open on DART
- Other Market Notice (Occurrence of Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 사유 발생)Jul 16, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항Jul 16, 2026Open on DART
- Exchange inquiry about a news report or price move조회공시요구(풍문또는보도)Jul 15, 2026Open on DART
- Trading halt매매거래정지및정지해제(풍문등조회공시)Jul 15, 2026Open on DART
- Adjustment of Conversion Price, Warrant Exercise Price and Exchange Price (Informational Disclosure)전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)Jun 29, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Jun 29, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 29, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 29, 2026Open on DART
- Amended: Exchange inquiry about a news report or price move[기재정정]조회공시요구(풍문또는보도)에대한답변(부인)Jun 18, 2026Open on DART
- Exchange inquiry about a news report or price move조회공시요구(풍문또는보도)에대한답변(부인)Jun 18, 2026Open on DART
- Material Matters Report (Decision on Acquisition of Own Convertible Bonds Before Maturity)주요사항보고서(자기전환사채만기전취득결정)Jun 18, 2026Open on DART
- Exchange inquiry about a news report or price move조회공시요구(풍문또는보도)Jun 17, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]유상증자결정(종속회사의주요경영사항)Jun 15, 2026Open on DART
- Amended: Acquisition of shares in another company[기재정정]타법인주식및출자증권취득결정Jun 15, 2026Open on DART
- Change of Representative Director (Representative Executive Officer) (Informational Disclosure)대표이사(대표집행임원)변경(안내공시)Jun 12, 2026Open on DART
- Results of Extraordinary Shareholders' Meeting임시주주총회결과Jun 11, 2026Open on DART
- Disclosure of Corporate Governance Report기업지배구조보고서공시Jun 1, 2026Open on DART
- [Attached Correction] Reference Documents for Proxy Solicitation for Exercise of Voting Rights[첨부정정]의결권대리행사권유참고서류Jun 1, 2026Open on DART
- [Amended Filing] Major Matters Report (Decision on Sale of Own Convertible Bonds)[기재정정]주요사항보고서(자기전환사채매도결정)May 29, 2026Open on DART
Titles in Korean until English translations are added.
Also known as: GeneOne Life Science / 진원생명과학 / 011000 / KRX:011000
Source: KRX statistical information